As we continue to improve our MiQLab® system — working towards the ability to detect more than 95% of all bacteria and at the same time lowering our manufacturing costs — we aim to explore expansion into multiple market verticals.
The MiQLab System ensures quality and safety with automated, near-line screening solution for microbial contamination control
On-site results eliminate the need to send samples out for testing enabling fast evidence-based treatment practices.
Obtain clinical insight in less time when critical answers matter. Rely on accurate molecular testing to improve the diagnostic and treatment process for better managed patient care.
Process samples cost-effectively on-site, screen for common pathogens, and manage the risk of contamination with molecular testing.
Shorten the time gap between pathogen identification enabling an organization to maximize containment efforts and minimize the impact on food, water, and people.